These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14998982)

  • 1. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.
    Athamna A; Massalha M; Athamna M; Nura A; Medlej B; Ofek I; Bast D; Rubinstein E
    J Antimicrob Chemother; 2004 Feb; 53(2):247-51. PubMed ID: 14688054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Bacillus anthracis isolates resistant to antibiotics.
    Athamna A; Athamna M; Abu-Rashed N; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Aug; 54(2):424-8. PubMed ID: 15205405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods.
    Luna VA; King DS; Gulledge J; Cannons AC; Amuso PT; Cattani J
    J Antimicrob Chemother; 2007 Sep; 60(3):555-67. PubMed ID: 17586563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF; Booker BM; Ogundele AB; Kelchin P
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):255-9. PubMed ID: 15935606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae.
    Frédénucci I; Chomarat M; Bercion R; Carricajo A; Celard M; Croizé J; Delubac F; Fèvre D; Fuhrmann C; Helfre M; Letouzey MN; Lelièvre H; Mandjee A; Marthelet P; Meley R; Perrier-Gros-Claude JD; Ros A; Roure C; Smati S; Thierry J; Tous J
    Clin Microbiol Infect; 2002 Oct; 8(10):680-3. PubMed ID: 12390289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
    Mory F; Fougnot S; Rabaud C; Schuhmacher H; Lozniewski A
    J Antimicrob Chemother; 2005 Feb; 55(2):265-8. PubMed ID: 15590714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
    Duewelhenke N; Krut O; Eysel P
    Antimicrob Agents Chemother; 2007 Jan; 51(1):54-63. PubMed ID: 17088489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of quinupristin/dalfopristin, linezolid, telithromycin and comparator antimicrobial agents against 13 species of coagulase-negative staphylococci.
    John MA; Pletch C; Hussain Z
    J Antimicrob Chemother; 2002 Dec; 50(6):933-8. PubMed ID: 12461014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
    Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.
    Bråbäck M; Riesbeck K; Forsgren A
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1114-6. PubMed ID: 11897601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
    Krausse R; Schubert S
    Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania.
    Caplan DM; Ivana S; Caplan ME
    Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
    Jones RN; Fritsche TR; Sader HS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-antibiotic effect induced by an antibiotic combination: influence of mode, sequence and interval of exposure.
    Li RC; Tang MC
    J Antimicrob Chemother; 2004 Nov; 54(5):904-8. PubMed ID: 15375112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.